Royal Pharmaceutical Society of Great Britain, Royal Pharmaceutical Society of Great Britain, London
Thursday 10 June 2010
09.30 Registration and coffee 10.00 Introduction - Ken Leiper, Chairman, Joint Pharmaceutical Analysis Group 10.05 Critical issues in the evaluation of stability data - Dr Paul Marshall, MHRA 10.40 Stability challenges in parenteral nutrition - Dr Allan Cosslett, University of Cardiff 11.15 Short break 11.25 Generating stability data to support current practice in aseptic compounding and the activities of a central IV additive service - Professor. Graham Sewell, University of Plymouth 12.00 Evaluating the stability of biological products - Dr Ahmed Yasin, GSK 12.35 Lunch and poster viewing** 13.35 Important aspects of oligonucleotide stability- Daren Levin, GSK, North Carolina 14.10 Investigating the stability of paediatric medicines - Dr Catherine Tuleu, University of London, School of Pharmacy 14.45 Tea break 15.05 Supporting the use of unlicensed medicines or ‘Specials’ with stability data - Tony Engel, Penn Pharma 15.40 Developing pharmacopoeial monographs for unlicensed medicines - Dr Ged Lee, The British Pharmacopoeia, MHRA 16.15 Closing remarks 16.20 Close
|
|